Struvite kidney stones, also known as infection stones, pose a significant health challenge, often arising from urinary tract infections caused by urease-producing bacteria. These bacteria convert urea in the urine into ammonia, increasing the urine's pH and facilitating the precipitation of magnesium ammonium phosphate (struvite). Acetohydroxamic Acid (AHA) has emerged as a critical therapeutic agent in preventing the formation of these stones. NINGBO INNO PHARMCHEM CO.,LTD. provides high-quality Acetohydroxamic Acid (CAS 546-88-3), a compound vital for mitigating this condition.

The efficacy of Acetohydroxamic Acid in preventing kidney stones lies in its potent and irreversible inhibition of the urease enzyme. By blocking urease activity, AHA prevents the conversion of urea to ammonia. This action helps to maintain a lower urine pH, thereby hindering the crystallization of struvite and other alkaline encrustations. For individuals prone to infection-induced kidney stones, regular use of this compound, under medical supervision, can significantly reduce recurrence rates. The demand for effective acetohydroxamic acid for kidney stones management underscores its importance in urology and nephrology.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supplying the medical and research communities with Acetohydroxamic Acid of the highest purity (99%). This ensures that patients receive a safe and effective treatment, and researchers have a reliable compound for their studies. Understanding the chemical properties and therapeutic benefits of Acetohydroxamic Acid is crucial for healthcare professionals. If you are seeking a trusted supplier to purchase acetohydroxamic acid for medical or research purposes, NINGBO INNO PHARMCHEM CO.,LTD. offers a dependable source with excellent product quality and support.